Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.5
2.4
Journals
Healthcare
Special Issues
The Latest Advances in Visual Health
share announcement

The Latest Advances in Visual Health

A special issue of Healthcare (ISSN 2227-9032).

Deadline for manuscript submissions: 31 May 2025 | Viewed by 2417

Special Issue Editor

Dr. Maria Serramito-Blanco

E-Mail Website
Guest Editor
Department of Optometry and Vision, Faculty of Optics and Optometry, Ocupharm Research Group, Complutense University of Madrid, 28037 Madrid, Spain
Interests: optometry and vision; contact lenses; ocular surface; dry eye; irregular cornea; refraction
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vision plays a fundamental role in our daily lives, from mundane tasks to precise activities. Therefore, protecting eye health is crucial to maintaining a good quality of life. Optometry emerges as an indispensable ally in this task. This area of health sciences is dedicated to preserving visual health and correcting refractive errors through comprehensive eye examinations. It applies the necessary techniques for detecting, following up, and rehabilitating visual health anomalies and manages the prevention of eye diseases.

It is currently an open research field for development. At the same time, it should be studied alongside other areas such as ophthalmology, pediatrics, psychology, education, physical activity, and computer science, including artificial intelligence (AI).

AI is revolutionizing the eye and vision health landscape, offering innovative solutions to improve diagnostic accuracy, personalized treatments, and efficiency of patient care.

This Special Issue aims to explore the ever-evolving landscape of eye health, highlighting new clinical approaches, technological advances, and their integration with artificial intelligence (AI). It is intended to provide insight into novel techniques in clinical practice, experimental, analysis, detection, anomaly tracking, treatment and visual rehabilitation, instrumentation for diagnosis and improvement of visual quality, and the ethical and social impact of AI in the eye area. In addition, it can be a platform to foster collaboration between the scientific community and industry and to foster the development of innovative AI-based solutions to improve the visual health of the population.

We invite the submission of original and review articles that address the latest advances in eye health, with a particular emphasis on the role of AI as a transformative tool in this field.

Dr. Maria Serramito-Blanco
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • eye
  • vision
  • ocular
  • visual health
  • optometry
  • ophthalmology
  • artificial intelligence
  • detection of eye anomalies
  • ocular treatment
  • refraction
  • ocular diseases
  • ocular rehabilitation
  • developments in visual health

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

13 pages, 4277 KiB  
Article
Efficacy and Safety of Accelerated Transepithelial Corneal Crosslinking in Non-Pediatric Patients with Progressive Keratoconus: Insights from a Retrospective Cohort Study
by Alina-Cristina Chiraples, Mihnea Munteanu, Horia T. Stanca, Diana-Maria Darabus, Diana Barakat and Alina-Gabriela Negru
Healthcare 2025, 13(5), 567; https://doi.org/10.3390/healthcare13050567 - 6 Mar 2025
Viewed by 602
Abstract
Background/Objectives: Transepithelial accelerated corneal crosslinking (TE-ACXL) is a minimally invasive approach for stabilizing progressive keratoconus while preserving the corneal epithelium. This study aims to evaluate changes in visual acuity, refractive error, and corneal parameters before and six months after TE-ACXL. Methods: A retrospective [...] Read more.
Background/Objectives: Transepithelial accelerated corneal crosslinking (TE-ACXL) is a minimally invasive approach for stabilizing progressive keratoconus while preserving the corneal epithelium. This study aims to evaluate changes in visual acuity, refractive error, and corneal parameters before and six months after TE-ACXL. Methods: A retrospective analysis was conducted on 30 eyes from 20 patients who underwent TE-ACXL between May 2021 and June 2023. Variables included were uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), spherical and cylindrical refractive error, and corneal tomography parameters such as maximum keratometry (Kmax), the symmetry index (Si), the keratoconus vertex (KV), Baiocchi–Calossi–Versaci index (BCV), thinnest corneal thickness (TCT), and central corneal thickness (CCT). Results: CDVA improved from 0.20 ± 0.22 to 0.06 ± 0.11 LogMAR (p = 0.004), while UDVA improved from 0.47 ± 0.35 to 0.29 ± 0.30 LogMAR (p < 0.001). Spherical and cylindrical refractive error showed significant reductions from −2.18 ± 3.05 D to −1.31 ± 1.84 D (p < 0.001) and −3.33 ± 1.98 D to −2.33 ± 1.52 D (p < 0.001), respectively. Pachymetry values decreased significantly, with TCT reducing from 466.43 ± 31.24 µm to 438.63 ± 30.54 µm (p < 0.001) and CCT from 480.80 ± 33.24 µm to 451.23 ± 29.26 µm (p < 0.001). Kmax showed a modest reduction (52.33 ± 3.51 D to 51.19 ± 3.63 D, p < 0.001), while other topographic indices, including Si, KV, and BCV, exhibited minor, non-significant changes, except for BCV back (p = 0.031). Conclusions: TE-ACXL was associated with significant improvements in visual acuity and refractive stability at six months postoperatively while maintaining a favorable safety profile. The procedure may serve as an effective option for early intervention in progressive keratoconus. Full article
(This article belongs to the Special Issue The Latest Advances in Visual Health)
►▼ Show Figures

Figure 1

17 pages, 2488 KiB  
Article
Deciphering the Physical Characteristics of Ophthalmic Filters Used in Optometric Vision Therapy
by Danjela Ibrahimi, Marcos Aviles, Guillermo Valencia Luna and Juvenal Rodriguez Resendiz
Healthcare 2024, 12(21), 2177; https://doi.org/10.3390/healthcare12212177 - 31 Oct 2024
Viewed by 1237
Abstract
Background: This paper aimed to measure and characterize eleven monochromatic filters and twenty-two combinations used empirically to treat patients with visual dysfunctions to propose enhanced protocols based on solid evidence. Their wavelength, transmittance, and relative sensitivity were defined on the retinal cone cells. [...] Read more.
Background: This paper aimed to measure and characterize eleven monochromatic filters and twenty-two combinations used empirically to treat patients with visual dysfunctions to propose enhanced protocols based on solid evidence. Their wavelength, transmittance, and relative sensitivity were defined on the retinal cone cells. Methods: A double-beam UV-VIS-NIR spectrophotometer, VARIAN brand, Cary 5000 model, owned by the National Center of Metrology, with high precision and accuracy, was used to characterize all filters. Filters were purchased from Optomatters Corporation, Belgium. Results: When two or three filters are combined, their transmittance and relative sensitivity on the retinal cone cells decrease regardless of wavelength. As a result, the efficiency of combined filters may decrease during treatments. Additionally, most filters and combinations, regardless of the wavelength, transmit a considerable percentage of light from the red spectrum. A depressant is the best monochromatic filter, and Upsilon–Neurasthenic is the strongest combination to stimulate blue cone cells. In contrast, Stimulant and Delta–Theta are best for red and green cone cells. Mu–Delta and Mu–Theta can be interchangeable, as well as Alpha–Delta and Alpha–Theta. Conclusions: Results suggest that the current phototherapy treatment protocol must be deeply revised, and the number of filters and combinations should be reduced to reduce costs and time and boost efficiency. Full article
(This article belongs to the Special Issue The Latest Advances in Visual Health)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop